Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART

by Pierre Gantner, Amélie Pagliuzza, Marion Pardons, Moti Ramgopal, Jean-Pierre Routy, Rémi Fromentin, Nicolas Chomont
Published 2020-08-01

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.

by Pierre Gantner, Firouze Bani-Sadr, Rodolphe Garraffo, Pierre-Marie Roger, Michèle Treger, Thomas Jovelin, Pascal Pugliese, David Rey, Dat’AIDS cohort
Published 2016-01-01

Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center.

by Pierre Gantner, Michele Treger, Constance De Miscault, Marie-Laure Batard, Claudine Bernard-Henry, Christine Cheneau, Erik De Mautort, Marialuisa Partisani, Michele Priester, David Rey
Published 2015-01-01

In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia

by Basiel Cole, Laurens Lambrechts, Pierre Gantner, Ytse Noppe, Noah Bonine, Wojciech Witkowski, Lennie Chen, Sarah Palmer, James I. Mullins, Nicolas Chomont, Marion Pardons, Linos Vandekerckhove
Published 2021-06-01

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.

by Pierre Gantner, Laurent Cotte, Clotilde Allavena, Firouzé Bani-Sadr, Thomas Huleux, Claudine Duvivier, Marc-Antoine Valantin, Christine Jacomet, Véronique Joly, Antoine Chéret, Pascal Pugliese, Pierre Delobel, André Cabié, David Rey, Dat’AIDS Study Group
Published 2019-01-01

"Real life" use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study.

by Pierre Gantner, Babacar Sylla, Laurence Morand-Joubert, Pierre Frange, Karine Lacombe, Marie-Aude Khuong, Claudine Duvivier, Odile Launay, Marina Karmochkine, Cédric Arvieux, Amélie Ménard, Lionel Piroth, Ana Canestri, Dominique Trias, Gilles Peytavin, Roland Landman, Jade Ghosn, Coferal-IMEA048 Study Group
Published 2019-01-01

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

by Floriane Gallais, Pierre Gantner, Timothée Bruel, Aurélie Velay, Delphine Planas, Marie-Josée Wendling, Sophie Bayer, Morgane Solis, Elodie Laugel, Nathalie Reix, Anne Schneider, Ludovic Glady, Baptiste Panaget, Nicolas Collongues, Marialuisa Partisani, Jean-Marc Lessinger, Arnaud Fontanet, David Rey, Yves Hansmann, Laurence Kling-Pillitteri, Olivier Schwartz, Jérome De Sèze, Nicolas Meyer, Maria Gonzalez, Catherine Schmidt-Mutter, Samira Fafi-Kremer
Published 2021-09-01